Roche (PINK:RHHBY) tapped Vivonoetics and Great Lakes NeuroTechnologies, to provide a wearable respiratory testing device to Roche’s Firefish study. The company’s study aims to evaluate drug efficacy compared to respiratory muscle function and breathing patterns in infants treated for spinal muscular atrophy. Devices traditionally used to measure breathing include masks and mouthpieces, which aren’t always practical for monitoring infants. […]
Roche
Senseonics, Roche expand distribution deal for Eversense glucose monitor
Senseonics (NYSE:SENS) said today that it expanded its exclusive distribution agreement with Roche (PINK:RHHBY) for its implantable continuous glucose monitoring system for people with diabetes. The new agreement includes all of Europe, the Middle East and Africa, excluding Scandinavia, Finland and Israel. According to the agreement, Germantown, Maryland-based Senseonics has given Roche exclusive rights to promote, […]
Report: J&J raises the stakes in Actelion pursuit
Johnson & Johnson (NYSE:JNJ) has reportedly raised its offer for Swiss biotech firm Actelion Pharmaceuticals (VTX:ATLN), pressuring the company to accept a takeover deal. The companies have been in talks for nearly 2 months but so far have not reached a deal, according to Reuters. The news outlet reported that Actelion wants J&J to become a major shareholder […]
Trump win boosts drug stocks
Pharmaceutical stocks surged today after Donald Trump won the U.S. presidential election, as investors concluded the threat of action on drug pricing had lessened. California’s Proposition 61, which would have prevented the state of California from purchasing drugs from a manufacturer for a price higher than that paid by the U.S. Veterans Affairs Dept., failed to […]
FDA approves Genentech’s Lucentis pre-filled ranibizumab syringe
Genentech, a member of the Roche group (PINK:RHHBY), said today that it won FDA clearance for its Lucentis (ranibizumab injection) pre-filled syringes. The anti-VEGF medicine is FDA-approved to treat wet age-related macular degeneration and macular edema after retinal vein occlusion. The pre-filled syringe enables physicians to eliminate steps in preparation and administration process, the company […]
Roche launches next-gen glucose monitor
Roche (PINK:RHHBY) said yesterday it launched its Accu-Check Guide next-generation blood glucose monitoring system, with an initial launch in Denmark, Switzerland and Australia. The new system features the company’s SmartPack” spill-resistant test strip vial designed to avoid strip spillage or contamination. “As the global leader in diabetes management we are dedicated to supporting people with diabetes, in […]
Senseonics inks exclusive Eversense CGM EU distro deal with Roche
Senseonics (OTC:SENH) said today it inked an exclusive distribution agreement with Roche (PINK:RHHBY) for the multi-country commercialization of the Eversense continuous glucose monitor. Under the deal, Roche has the exclusive rights to promote, market and sell the Eversense product portfolio to diabetes clinics and patients in Germany, Italy and the Netherlands, Senseonics said. The Eversense system includes an implanted […]
Diabetes: FDA OKs 1st glucose meter with insulin calculator
Biotech titan Roche secured a landmark FDA win with clearance for its Accu-Chek Aviva Expert blood glucose meter, the 1st of its kind with a built-in insulin calculator to help guide patient therapy.
Press Release: ACCU-CHEK Aviva Expert, the first and only stand-alone blood glucose meter system with a built-in insulin calculator, is now available
Medtech personnel moves for the week of Mar. 10, 2014
ConMed proxy war gets ugly
February 28, 2014 by Brad Perriello
The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.
Madaus is new CEO at Carlyle’s Ortho-Clinical Diagnostics
The Carlyle Group said it tapped Martin Madaus to take over as CEO of the Ortho-Clinical Diagnostics business it’s acquiring from Johnson & Johnson (NYSE:JNJ).